Literature DB >> 26299317

Grapefruit Juice and Statins.

Jonathan W Lee1, Joan K Morris1, Nicholas J Wald2.   

Abstract

We determined the validity of current medical advice to avoid grapefruit juice consumption while taking 3 widely used statins. A daily glass of grapefruit juice increases blood levels of simvastatin and lovastatin by about 260% if taken at the same time (about 90% if taken 12 hours apart), and atorvastatin by about 80% (whenever taken). Simvastatin 40 mg, lovastatin 40 mg, and atorvastatin 10 mg daily reduce low-density lipoprotein (LDL) cholesterol levels in a 60-year-old man with an LDL cholesterol of 4.8 mmol/L by 37%, reducing ischemic heart disease risk by 61%. When simvastatin or lovastatin are taken at the same time as grapefruit juice, the estimated reduction in LDL cholesterol is 48%, and in heart disease is 70%. If the juice is taken 12 hours before these statins, the reductions are, respectively, 43% and 66%, and for atorvastatin, 42% and 66%. The increased rhabdomyolysis risk from grapefruit juice consumption due to the increased effective statin dose is minimal compared with the greater effect in preventing heart disease. Grapefruit juice should not be contraindicated in people taking statins.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Drug interaction; Effect enhancer; Grapefruit juice; Ischemic heart disease; LDL cholesterol; Statins

Mesh:

Substances:

Year:  2015        PMID: 26299317     DOI: 10.1016/j.amjmed.2015.07.036

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  13 in total

Review 1.  A Review of Statin Intolerance: a Focus on Statin-Attributed Muscle Symptoms.

Authors:  Carl E Orringer; Jelani K Grant; Lale Tokgozoglu
Journal:  Curr Atheroscler Rep       Date:  2022-08-24       Impact factor: 5.967

2.  Effects of Grapefruit and Pomegranate Juices on the Pharmacokinetic Properties of Dapoxetine and Midazolam in Healthy Subjects.

Authors:  Khaled S Abdlekawy; Ahmed M Donia; Fawzy Elbarbry
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-06       Impact factor: 2.441

3.  Fat burn X: burning more than fat.

Authors:  Kyle Hannabass; Kevin Robert Olsen
Journal:  BMJ Case Rep       Date:  2016-01-25

Review 4.  Bioactivity of Polyphenols: Preventive and Adjuvant Strategies toward Reducing Inflammatory Bowel Diseases-Promises, Perspectives, and Pitfalls.

Authors:  Anouk Kaulmann; Torsten Bohn
Journal:  Oxid Med Cell Longev       Date:  2016-07-10       Impact factor: 6.543

5.  Grapefruit: Some perspectives in pharmacology and nutrition.

Authors:  Sergei V Jargin
Journal:  J Intercult Ethnopharmacol       Date:  2017-05-30

Review 6.  Food and Drug Interactions.

Authors:  Jong Hwan Choi; Chang Mann Ko
Journal:  J Lifestyle Med       Date:  2017-01-31

7.  The Herb-Drug Pharmacokinetic Interaction of Fluoxetine and Its Metabolite Norfluoxetine with a Traditional Chinese Medicine in Rats by LC-MS/MS.

Authors:  Lijing Yan; Sheng Wang; Linlin Zhao; Juan Qiu; Lu Zhou; Wenbo Wang; Xia Xu; Dongsheng Wang; Xinjian Qiu; Dilan Qin
Journal:  Evid Based Complement Alternat Med       Date:  2019-11-30       Impact factor: 2.629

Review 8.  Toward a broader view of mechanisms of drug cardiotoxicity.

Authors:  Polina Mamoshina; Blanca Rodriguez; Alfonso Bueno-Orovio
Journal:  Cell Rep Med       Date:  2021-03-16

9.  Fixed Dose Single Tablet Formulation with Differential Release of Amlodipine Besylate and Simvastatin and Its Pharmacokinetic Profile: QbD and Risk Assessment Approach.

Authors:  Ummarah Kanwal; Shahid Mukhtar; Muzzamil Waheed; Arifa Mehreen; Nasir Abbas; Rahat Shamim; Khalid Hussain; Fatima Rasool; Amjad Hussain; Nadeem Irfan Bukhari
Journal:  Drug Des Devel Ther       Date:  2021-05-24       Impact factor: 4.162

Review 10.  Pharmacokinetic Interactions between Cardiovascular Medicines and Plant Products.

Authors:  Irina-Iuliana Costache; Anca Miron; Monica Hăncianu; Viviana Aursulesei; Alexandru Dan Costache; Ana Clara Aprotosoaie
Journal:  Cardiovasc Ther       Date:  2019-09-02       Impact factor: 3.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.